These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10960037)

  • 21. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors.
    El-Tayeb A; Qi A; Müller CE
    J Med Chem; 2006 Nov; 49(24):7076-87. PubMed ID: 17125260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure activity and molecular modeling analyses of ribose- and base-modified uridine 5'-triphosphate analogues at the human P2Y2 and P2Y4 receptors.
    Jacobson KA; Costanzi S; Ivanov AA; Tchilibon S; Besada P; Gao ZG; Maddileti S; Harden TK
    Biochem Pharmacol; 2006 Feb; 71(4):540-9. PubMed ID: 16359641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH.
    King BF; Ziganshina LE; Pintor J; Burnstock G
    Br J Pharmacol; 1996 Apr; 117(7):1371-3. PubMed ID: 8730726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P2 purinergic receptors of human eosinophils: characterization and coupling to oxygen radical production.
    Ferrari D; Idzko M; Dichmann S; Purlis D; Virchow C; Norgauer J; Chiozzi P; Di Virgilio F; Luttmann W
    FEBS Lett; 2000 Dec; 486(3):217-24. PubMed ID: 11119707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
    Ivanov AA; Ko H; Cosyn L; Maddileti S; Besada P; Fricks I; Costanzi S; Harden TK; Calenbergh SV; Jacobson KA
    J Med Chem; 2007 Mar; 50(6):1166-76. PubMed ID: 17302398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of anions on ATP-induced [Ca2+], increase in NG108-15 cells.
    Watano T; Matsuoka I; Ogawa K; Kimura J
    Jpn J Pharmacol; 2002 Jul; 89(3):302-8. PubMed ID: 12184737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2Y(2) receptor stimulation increases tear fluid secretion in rabbits.
    Murakami T; Fujihara T; Nakamura M; Nakata K
    Curr Eye Res; 2000 Oct; 21(4):782-7. PubMed ID: 11120568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulation of nitric oxide synthase by endothelial purinoceptors does not correlate with inositol trisphosphate levels.
    Brown CA; Wilkinson GF; Boarder MR
    Biochem Soc Trans; 1995 Aug; 23(3):425S. PubMed ID: 8566313
    [No Abstract]   [Full Text] [Related]  

  • 29. Extracellular ATP inhibits starvation-induced apoptosis via P2X2 receptors in differentiated rat pheochromocytoma PC12 cells.
    Fujita N; Kakimi M; Ikeda Y; Hiramoto T; Suzuki K
    Life Sci; 2000 Mar; 66(19):1849-59. PubMed ID: 10809182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrasting effects of P2 receptor agonists on spontaneous contractility of human fallopian tubes with and without acute inflammation.
    Ziganshin AU; Vafina ZR; Fatkullin IF
    Pharmacol Res; 2008 Jan; 57(1):56-9. PubMed ID: 18155558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Insights in Purinergic Therapy: Novel Antagonists for Uridine 5'-Triphosphate-Activated P2Y Receptors from Brazilian Flora.
    Ferreira NCDS; Soares-Bezerra RJ; da Silveira RFC; da Silva CM; de Oliveira CS; Calheiros AS; Alves TM; Zani CL; Alves LA
    J Med Food; 2019 Feb; 22(2):211-224. PubMed ID: 30526214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How should P2X purinoceptors be classified pharmacologically?
    Kennedy C; Leff P
    Trends Pharmacol Sci; 1995 May; 16(5):168-74. PubMed ID: 7624972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culture substrate-specific expression of P2Y2 receptors in distal lung epithelial cells isolated from foetal rats.
    Clunes MT; Collett A; Baines DL; Bovell DL; Murphie H; Inglis SK; McAlroy HL; Olver RE; Wilson SM
    Br J Pharmacol; 1998 Jul; 124(5):845-7. PubMed ID: 9692767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of acetylcholine-activated current by low concentrations of extracellular adenosine 5'-triphosphate.
    Nakazawa K; Ito K; Koizumi S; Ohno Y; Inoue K
    Life Sci; 1995; 57(22):PL351-6. PubMed ID: 7475947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of agonist-induced desensitization and sequestration of the P2Y2 nucleotide receptor. Consequences of truncation of the C terminus.
    Garrad RC; Otero MA; Erb L; Theiss PM; Clarke LL; Gonzalez FA; Turner JT; Weisman GA
    J Biol Chem; 1998 Nov; 273(45):29437-44. PubMed ID: 9792648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purine and pyrimidine (P2) receptors as drug targets.
    Jacobson KA; Jarvis MF; Williams M
    J Med Chem; 2002 Sep; 45(19):4057-93. PubMed ID: 12213051
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
    Pendergast W; Yerxa BR; Douglass JG; Shaver SR; Dougherty RW; Redick CC; Sims IF; Rideout JL
    Bioorg Med Chem Lett; 2001 Jan; 11(2):157-60. PubMed ID: 11206448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ATP and neuropathic pain].
    Inoue K; Tsuda M; Koizumi S
    Seikagaku; 2004 Nov; 76(11):1431-9. PubMed ID: 15626030
    [No Abstract]   [Full Text] [Related]  

  • 39. Intracellular disulfide bond that affects ATP responsiveness of P2X2 receptor/channel.
    Nakazawa K; Ojima H; Ishii-Nozawa R; Takeuchi K; Ohno Y
    Eur J Pharmacol; 2003 Aug; 474(2-3):205-8. PubMed ID: 12921863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purinergic P2X4 receptors are involved in the modulation of giant depolarizing potentials in the hippocampus of newborn rat.
    Safiulina VF; Bikbulatova LS; Mel'nik AI; Rebrov IG; Bazian AS
    Dokl Biol Sci; 2005; 403():250-2. PubMed ID: 16358563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.